Spiriva and Upper respiratory tract infection - a phase IV clinical study of FDA data
Summary:
Upper respiratory tract infection is reported as a side effect among people who take Spiriva (tiotropium bromide monohydrate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Singulair, and have Immunodeficiency common variable.
The phase IV clinical study analyzes which people have Upper respiratory tract infection when taking Spiriva. It is created by eHealthMe based on reports of 155,418 people who have side effects when taking Spiriva from the FDA, and is updated regularly.
What is Spiriva?
Spiriva has active ingredients of tiotropium bromide monohydrate. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 156,666 Spiriva users. Check the latest studies of Spiriva.
What is Upper respiratory tract infection?
Upper respiratory tract infection is found to be associated with 1,900 drugs and 1,773 conditions by eHealthMe. Check the latest studies of Upper respiratory tract infection.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
155,418 people reported to have side effects when taking Spiriva.
Among them, 1,592 people (1.02%) have Upper respiratory tract infection.
Among these 1,592 people:
How long have people been on Spiriva when they have Upper respiratory tract infection? *
What is the gender of people who have Upper respiratory tract infection when taking Spiriva? *
What is the age of people who have Upper respiratory tract infection when taking Spiriva? *
What are other drugs people take besides Spiriva? *
What are other side effects people have besides Upper respiratory tract infection? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Spiriva and have Upper respiratory tract infection?
- Check whether Upper respiratory tract infection is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Spiriva:
- Spiriva (156,666 reports)
Upper respiratory tract infection treatments and more:
- Upper respiratory tract infection (64,928 reports)
How severe was Upper respiratory tract infection and when was it recovered:
Expand to all the drugs that have ingredients of tiotropium bromide monohydrate:
- Upper respiratory tract infection and drugs with ingredients of tiotropium bromide monohydrate (1,636 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Spiriva:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Upper respiratory tract infection:
- Upper respiratory tract infection (1,900 drugs)
Browse all the conditions that are associated with Upper respiratory tract infection:
- Upper respiratory tract infection (1,773 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on tiotropium bromide monohydrate (the active ingredients of Spiriva) and Spiriva (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Lopressor and Spinal Osteoarthritis for Women aged 40-49 - 16 seconds ago
- Losartan and Synthroid drug interactions for men aged 50-59 - 31 seconds ago
- Imuran and Colitis Ulcerative for Men aged 50-59 - 33 seconds ago
- Imuran and Uc for Men aged 50-59 - 33 seconds ago
- Imuran and Inflammatory Bowel Disease - Ulcerative Colitis for Men aged 50-59 - 33 seconds ago
- Imuran and Ulcerative Colitis for Men aged 50-59 - 34 seconds ago
- Xanax and Vasovagal for Men aged 50-59 - 48 seconds ago
- Xanax and Syncope for Men aged 50-59 - 48 seconds ago
- Xanax and Passed Out for Men aged 50-59 - 48 seconds ago
- Xanax and Lightheadedness - Fainting for Men aged 50-59 - 49 seconds ago